Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
American Journal of Clinical Oncology|July 23, 2020
Psychiatric Disturbance or Parkinsonism as a Presentation of CNS Lymphoma: Observational Retrospective Study and Review of LiteratureAkanksha Sharma, Sophia Dube, Luke Mountjoy, et al.Leukemia & Lymphoma|April 14, 2020
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantationLuke Mountjoy, Tania Jain, Katie L Kunze, et al.Blood Cancer Journal|March 12, 2020
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosisTania Jain, Katie L Kunze, Luke Mountjoy, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective StudyPedro L S Uson, Douglas Riegert-Johnson, Lisa Boardman, et al.Transplantation and Cellular Therapy|March 23, 2025
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in LymphomaUttam K Rao, Navneet S Majhail, Betsy Blunk, et al.JAMA Oncology|October 30, 2020
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer SyndromeN Jewel Samadder, Douglas Riegert-Johnson, Lisa Boardman, et al.The New England Journal of Medicine|November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.Transplantation and Cellular Therapy|June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.Blood Advances|May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS InvolvementIbrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.Pageof 2